Table: Kaken Pharmaceutical -9-MTH group results

KAKEN PHARMACEUTICAL

05/02/2016 04:30

Feb 5 (Reuters)-  
             Kaken Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2015        Dec 31, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             85.43               71.16           107.90     
                 (+20.1 pct)         (+6.2 pct)       (+14.9 pct)  
  Operating         29.69               16.61            32.20     
                 (+78.7 pct)         (+40.4 pct)      (+56.1 pct)  
  Recurring         29.92               16.47            32.40     
                 (+81.6 pct)         (+41.8 pct)      (+58.9 pct)  
  Net               20.13                9.61            19.20     
                (+109.6 pct)         (+29.3 pct)      (+58.4 pct)  
  EPS            486.14 yen          230.05 yen       463.70 yen   
  Ann Div                             59.00 yen                    
  -Q2 div         34.00 yen           27.00 yen                    
  -Q4 div                             32.00 yen        78.00 yen   
   
  NOTE - Kaken Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T 
  ((Tokyo Headline News Desk +813 6441 1812))